Earnings Feed
Sign Up
Home/Filings/4/0001179110-13-015568
4//SEC Filing

Astex Pharmaceuticals, Inc 4

Accession 0001179110-13-015568

CIK 0000919722operating
View on SEC.govCompany Profile

Filed

Oct 15, 8:00 PM ET

Accepted

Oct 16, 7:31 PM ET

Size

26.9 KB

Accession

0001179110-13-015568

Insider Transaction Report

Form 4
Period: 2013-10-11
Astex Pharmaceuticals, IncASTX
Buckland Martin
Chief Business Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2013-10-11−26,192→ 0 total
    Exercise: $0.84From: 2011-07-20Exp: 2015-12-01→ Common Stock (26,192 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2013-10-11−19,644→ 0 total
    Exercise: $0.87From: 2011-07-20Exp: 2016-12-01→ Common Stock (19,644 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2013-10-11−180,000→ 0 total
    Exercise: $1.89Exp: 2022-03-07→ Common Stock (180,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2013-10-11−98,220→ 0 total
    Exercise: $0.92Exp: 2020-05-28→ Common Stock (98,220 underlying)
  • Disposition from Tender

    Common Stock

    2013-10-11−5,963→ 0 total
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2013-10-11−52,384→ 0 total
    Exercise: $0.70From: 2011-07-20Exp: 2014-09-30→ Common Stock (52,384 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2013-10-11−150,000→ 0 total
    Exercise: $2.21Exp: 2021-09-16→ Common Stock (150,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2013-10-11−32,085→ 0 total
    Exercise: $0.79Exp: 2019-06-22→ Common Stock (32,085 underlying)
Footnotes (17)
  • [F1]The number of shares disposed of represents 5,963 shares acquired under the Issuer's 2008 Employee Stock Purchase Plan.
  • [F10]The option originally provided for vesting as to 1/4th of the shares on May 28, 2011 and as to 1/48th of the shares on each one month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
  • [F11]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $744,507.60, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F12]The option originally provided for vesting as to 1/4th of the shares on September 16, 2012 and as to 1/48th of the shares on each one month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
  • [F13]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $943,500.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F14]The option originally provided for vesting as to 1/48th of the shares on April 7, 2012 and each one month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
  • [F15]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $1,189,800.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F16]The option originally provided for vesting as to 1/48th of the shares on January 6, 2013 and each one month anniversary thereafter. Pursuant to the Merger Agreement, the option vested in full immediately prior to the closing of the merger.
  • [F17]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $1,042,200.00, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F2]Pursuant to the Agreement and Plan of Merger, dated September 5, 2013, between the Issuer, Otsuka Pharmaceutical Co. Ltd., and Autumn Aquisition Corporation (the "Merger Agreement"), each share of Common Stock was exchanged for $8.50 in cash.
  • [F3]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $408,595.20, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F4]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $200,630,72, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F5]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $149,833.72, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F6]The option originally provided for vesting as to 1/4th of the shares on June 24, 2009 and as to 1/48th of the shares on each one month anniversary thereafter.
  • [F7]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $203,511.84, which represents the difference between $8.50 and the exercise price of the option per share.
  • [F8]The option originally provided for vesting as to 1/4th of the shares on June 22, 2010 and as to 1/48th of the shares on each one month anniversary thereafter.
  • [F9]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $247,375.35, which represents the difference between $8.50 and the exercise price of the option per share.

Documents

1 file

Issuer

Astex Pharmaceuticals, Inc

CIK 0000919722

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000919722

Filing Metadata

Form type
4
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 7:31 PM ET
Size
26.9 KB
View on SEC.gov